GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (XPAR:BOI) » Definitions » Market Cap

Boiron (XPAR:BOI) Market Cap : €464.4 Mil (As of Dec. 15, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Boiron Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Boiron's share price for the quarter that ended in Jun. 2024 was €31.35. Boiron's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 17.4 Mil. Therefore, Boiron's market cap for the quarter that ended in Jun. 2024 was €544.3 Mil.

Boiron's quarterly market cap increased from Jun. 2023 (€680.6 Mil) to Dec. 2023 (€698.3 Mil) but then declined from Dec. 2023 (€698.3 Mil) to Jun. 2024 (€544.3 Mil).

Boiron's annual market cap increased from Dec. 2021 (€626.0 Mil) to Dec. 2022 (€880.9 Mil) but then declined from Dec. 2022 (€880.9 Mil) to Dec. 2023 (€698.3 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Boiron's Enterprise Value for Today is €426.0 Mil.


Boiron Market Cap Historical Data

The historical data trend for Boiron's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron Market Cap Chart

Boiron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 637.34 724.19 626.04 880.95 698.31

Boiron Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 715.57 880.95 680.60 698.31 544.31

Competitive Comparison of Boiron's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boiron's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Boiron's Market Cap distribution charts can be found below:

* The bar in red indicates where Boiron's Market Cap falls into.



Boiron Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Boiron's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€40.22*17.3623
=€698.3

Boiron's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=€31.35*17.3623
=€544.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boiron  (XPAR:BOI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Boiron Market Cap Related Terms

Thank you for viewing the detailed overview of Boiron's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Boiron Business Description

Traded in Other Exchanges
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Boiron Headlines

No Headlines